IGA NEPHROPATHY
Clinical trials for IGA NEPHROPATHY explained in plain language.
Never miss a new study
Get alerted when new IGA NEPHROPATHY trials appear
Sign up with your email to follow new studies for IGA NEPHROPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New pill shows promise in slowing rare kidney disease
Disease control CompletedThis study tested a new drug called iptacopan (LNP023) in 518 adults with IgA nephropathy, a kidney disease that can lead to kidney failure. Participants took either the drug or a placebo alongside their usual care. The goal was to see if iptacopan could reduce protein in the uri…
Matched conditions: IGA NEPHROPATHY
Phase: PHASE3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated May 01, 2026 15:57 UTC
-
New drug shows promise for kidney disease in early trial
Disease control CompletedThis study tested an experimental drug called atrasentan in 54 adults with IgA nephropathy, a kidney disease. All participants were already on standard treatments, including SGLT2 inhibitors. The goal was to see if adding atrasentan could further reduce protein in the urine, a si…
Matched conditions: IGA NEPHROPATHY
Phase: PHASE2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Apr 30, 2026 15:52 UTC
-
New drug targets immune system to treat rare kidney diseases
Disease control CompletedThis study tested a new drug called ARO-C3 in 62 healthy adults and people with two types of kidney disease (C3 glomerulopathy and IgA nephropathy). The goal was to see if the drug is safe and how it works in the body. Participants received either the drug or a placebo, and the r…
Matched conditions: IGA NEPHROPATHY
Phase: PHASE1, PHASE2 • Sponsor: Arrowhead Pharmaceuticals • Aim: Disease control
Last updated Apr 29, 2026 15:05 UTC
-
New combo therapy aims to slow kidney disease in IgA patients
Disease control CompletedThis study tested whether adding early steroid treatment to standard blood pressure or diabetes medications can better control IgA nephropathy, a kidney disease. 62 adults with severe kidney damage on biopsy were randomly assigned to get either the combination or standard care al…
Matched conditions: IGA NEPHROPATHY
Phase: PHASE3 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Apr 29, 2026 15:02 UTC